Long-term follow-up of autologous stem-cell transplantation for follicular and transformed follicular lymphoma

European Journal of Haematology

Volumn 65, Issue 1, 2000, Pages 17-22

  Berglund, Åke ^a   Enblad, Gunilla ^a   Carlson, Kristina ^a   Glimelius, Bengt ^a   Hagberg, Hans ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Follicular lymphoma; High dose therapy; MDS; Total body irradiation; Transformed follicular lymphoma

Indexed keywords

BECENUM; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; UNCLASSIFIED DRUG;

ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOTRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; FOLLICULAR LYMPHOMA; HUMAN; MALE; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; WHOLE BODY RADIATION;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW PURGING; CARMUSTINE; CATARACT; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; CYTARABINE; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; ETOPOSIDE; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; INFECTION; LIFE TABLES; LYMPHOMA, FOLLICULAR; LYMPHOMA, HIGH-GRADE; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SWEDEN; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; WHOLE-BODY IRRADIATION;

EID: 0033919853     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2000.90114.x     Document Type: Article

References (20)

1. 1. ERSBOLL J, SHULZ HB, PEDERSEN-BJERGAARD J, et al. Follicular low grade non-Hodgkin's lymhoma: long-term outcome with or without tumor progression. Eur J Haematol 1989;42:155-163.
2. 2. OTTENSMEIER C, MEAD G. Histological transformation of indolent (follicular) lymphoma. Ann Oncol 1996;7:849-853.
3. 3. JOHNSON PW, PRICE CG, SMITH T, et al. Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for follicular lymphoma. Ann Oncol 1994;5 (Suppl 2):143-146.
4. 4. BASTION Y, BRICE P, HAIOUN C, et al. Intensive therapy with peripheral blood progenitor cell transplantations in 60 patients with poor-prognosis follicular lymphoma. Blood 1995;8:3257-3262.
5. 5. BIERMAN P, VOSE J, ANDERSON J, et al. High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma. J Clin Oncol 1997;2: 445-450.
6. 6. MOREL P, LAPORTE JP, NOEL MP, et al. Autologous bone marrow transplantation as consolidation therapy may prolong remission in newly diagnosed high-risk follicular lymphoma: a pilot study of 34 cases. Leukemia 1995;9:576-582.
7. 7. HAAS R, Moos M, MÖHLE R, et al. High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma. Bone Marrow Transplant 1996; 17:149-155.
8. 8. LINASSIER C, FOUILLARD L, MILPIED N, et al. Value of autologous bone marrow transplantation (ABMT) in 42 patients with follicular lymphomas responsive to conventional chemotherapy: a "France Autogreffe" study. Cancer Detect Prev 1996;20:11-19.
9. 9. FREEDMAN AS, GRIBBEN JG, NEUBERG D, et al. High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission. Blood 1996;88:2780-2786.
10. 10. SCHOUTEN HC, COLOMBAT PH, VERDONCK LF, et al. Autologous bone marrow transplantation for low-grade non-Hodgkin's lymphoma: The European Bone Marrow Transplant Group experience. Ann Oncol 1994;5:147-149.
11. 11. SCHOUTEN H, KVALOY S, SYDES M, et al. The CUP trial; A randomized study analyzing the efficacy of high dose therapy and purging in low-grade non-Hodgkin's lymphoma. Ann Oncol 1999;10:24.
12. 12. MILLER AB, HOOGSTRATEN B, STAQUET, et al. Reporting results of cancer treatment. Cancer 1981;47:207-14.
13. 13. YUEN AR, KAMEL OW, HALPERN J, HORNING SJ. Long-term survival after histological transformation of low-grade follicular lymphoma. J Clin Oncol 1995;7:1726-1733.
14. 14. SCHOUTEN HC, BIERMAN PJ, VAUGHAM WP, et al. Autologous bone marrow transplantation in follicular lymphoma before and after histologic transformation. Blood 1989;74:2579-2584.
15. 15. WILLIAMS CD, TAGHIPOUR G, LISTER TA, et al. Chemosensitive transformed follicular non-Hodgkin's lymphoma is a firm indication for high-dose therapy and autologous stem cell transplantation. A study from the EBMT registry. 38th Annual Meeting of the American Society of Hematology, Orlando. 6-10 December 1996.
16. 16. FORAN JM, APOSTOLIDIS J, PAPAMICHAEL D, et al. High-dose therapy with autologous hematopoetic support in patients with transformed follicular lymphoma: A study of 27 patients from a single centre. Ann Oncol 1998;9:865-869.
17. 17. DARRINGTON D, VOSE J, ANDERSON J, et al. Incidence and characterization of secondary myeloblastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies. J Clin Oncol 1994;12:2527-2534.
18. 18. LÖNNERHOLM G, CARLSON K, BRATTEBY L-E, et al. Renal function after autologous bone marrow transplantation. Bone Marrow Transplantation 1991;8:129-134.
19. 19. CARLSON K, BÄCKLUND L, SMEDMYR B, et al. Pulmonary function and complications subsequent to autologous bone marrow transplantation. Bone Marrow Transplantation 1994:14:805-811.
20. 20. CARLSON K, SMEDMYR B, BÄCKLUND L, SIMONSSON B. Subclinical disturbances in cardiac function at rest and in gas exchange during exercise are common findings after autologous bone marrow transplantation. Bone Marrow Transplantation 1994;14:949-954.